Código QR

Preclinical evaluation of ELP‐004 in mice

Abstract This study provides a detailed understanding of the preclinical pharmacokinetics and metabolism of ELP‐004, an osteoclast inhibitor in development for the treatment of bone erosion. Current treatments for arthritis, including biological disease‐modifying antirheumatic drugs, are not well‐to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Jamie L. McCall, Werner J. Geldenhuys, Lisa J. Robinson, Michelle R. Witt, Peter M. Gannett, Björn C. G. Söderberg, Harry C. Blair, Jonathan Soboloff, John B. Barnett
Formato: Artigo
Idioma:Inglês
Publicado: Wiley 2024-08-01
Series:Pharmacology Research & Perspectives
Assuntos:
Acceso en liña:https://doi.org/10.1002/prp2.1230
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!